What is New in Neuro-oncology?

被引：3

作者：

Thakkar, Jigisha P. ^{[1
]}

Prabhu, Vikram C. ^{[2
]}

Peters, Katherine B. ^{[3
]}

Lukas, Rimas V. ^{[4
,5
]}

机构：

[1] Loyola Univ Chicago, Stritch Sch Med, Div Neurooncol, Dept Neurol, 2160 South 1st Ave,Bldg 105,Room 2716, Maywood, IL 60153 USA

[2] Duke Univ, Sch Med, Dept Neurol Surg, 40 Duke Med Circle, Durham, NC 27711 USA

[3] Duke Univ, Sch Med, Dept Neurol, 40 Duke Med Circle, Durham, NC 27711 USA

[4] Northwestern Univ, Dept Neurol, 303 East Chicago Ave, Chicago, IL 60611 USA

[5] Robert H Lurie Comprehens Canc Ctr, Lou & Jean Malnati Brain Tumor Inst, Chicago, IL USA

来源：

NEUROLOGIC CLINICS | 2021年 / 39卷 / 01期

关键词：

Neuro-oncology update; Immune therapy; Targeted therapy; Brain tumor classification; NEWLY-DIAGNOSED GLIOBLASTOMA; RECURRENT GLIOBLASTOMA; OPEN-LABEL; PHASE-II; TEMOZOLOMIDE; EFFICACY; GRADE; INHIBITION; SURVIVAL; DELIVERY;

D O I：

10.1016/j.ncl.2020.09.009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Neuro-oncology remains dynamic and exciting. This review has attempted to highlight key studies that have affected clinical management and investigation in the recent past. In addition, the authors have discussed both completed and ongoing clinical trials at all phases of development. Although there remains a need for advances in neuro-oncology, it is hoped that our progressively growing understanding of these diseases will guide us quickly to translation of these findings to clinical improvements for our patients.

引用

页码：163 / 179

页数：17

共 72 条

[1] Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches [J].

Agrahari, Vivek ;

Agrahari, Vibhuti ;

Mitra, Ashim K. .

EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (03) :285-289

[2]

Ahluwalia M., 2020, CENTRAL NERVOUS SYST

[3]

Ahluwalia MRD AA, 2018, NEW ORLEANS SOC NEUR

[4] HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial [J].

Ahmed, Nabil ;

Brawley, Vita ;

Hegde, Meenakshi ;

Bielamowicz, Kevin ;

Kalra, Mamta ;

Landi, Daniel ;

Robertson, Catherine ;

Gray, Tara L. ;

Diouf, Oumar ;

Wakefield, Amanda ;

Ghazi, Alexia ;

Gerken, Claudia ;

Yi, Zhongzhen ;

Ashoori, Aidin ;

Wu, Meng-Fen ;

Liu, Hao ;

Rooney, Cliona ;

Dotti, Gianpietro ;

Gee, Adrian ;

Su, Jack ;

Kew, Yvonne ;

Baskin, David ;

Zhang, Yi Jonathan ;

New, Pamela ;

Grilley, Bambi ;

Stojakovic, Milica ;

Hicks, John ;

Powell, Suzanne Z. ;

Brenner, Malcolm K. ;

Heslop, Helen E. ;

Grossman, Robert ;

Wels, Winfried S. ;

Gottschalk, Stephen .

JAMA ONCOLOGY, 2017, 3 (08) :1094-1101

[5]

Alghamri MS., 2020, NEUROONCOL ADV, V2

[6]

Arrieta VA, 2019, J NEUROSURG, V132, P1313

[7] Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors [J].

Beccaria, Kevin ;

Canney, Michael ;

Bouchoux, Guillaume ;

Desseaux, Carole ;

Grill, Jacques ;

Heimberger, Amy B. ;

Carpentier, Alexandre .

CANCER LETTERS, 2020, 479 :13-22

[8]

Bloch O, 2017, NEURO-ONCOLOGY, V19, P29

[9] Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial [J].

Bloch, Orin ;

Parsa, Andrew T. .

NEURO-ONCOLOGY, 2014, 16 (05) :758-759

[10] Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG [J].

Blumenthal, Deborah T. ;

Gorlia, Thierry ;

Gilbert, Mark R. ;

Kim, Michelle M. ;

Nabors, L. Burt ;

Mason, Warren P. ;

Hegi, Monika E. ;

Zhang, Peixin ;

Golfinopoulos, Vassilis ;

Perry, James R. ;

Nam, Do Hyun ;

Erridge, Sara C. ;

Corn, Benjamin W. ;

Mirimanoff, Rene O. ;

Brown, Paul D. ;

Baumert, Brigitta G. ;

Mehta, Minesh P. ;

van den Bent, Martin J. ;

Reardon, David A. ;

Weller, Michael ;

Stupp, Roger .

NEURO-ONCOLOGY, 2017, 19 (08) :1119-1126

← 1 2 3 4 5 6 7 8 →